Diffus的e alveolar hemorrhage in immunocompetent.pptVIP

Diffus的e alveolar hemorrhage in immunocompetent.ppt

  1. 1、本文档共31页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  5. 5、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  6. 6、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  7. 7、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  8. 8、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
Diffuse alveolar hemorrhage in immunocompetent patients: Etiologies and prognosis revisited Respiratory Medicine (2012) 106, 1021e1032 Diffuse alveolar hemorrhage (DAH), commonly defined as the association of hemoptysis, new pulmonary infiltrates on chest x-ray and anemia, is a rare syndrome resulting from diffuse bleeding into the acinar portion of the lung. However, DAH can present in about 40% of the cases without hemoptysis. DAH is a diagnostic and therapeutic challenge because it may be revealed by nonspecific pulmonary manifestations and caused by multiple immune and non-immune disorders. Moreover, reported prognosis is poor, with in-hospital mortality ranging from 20 to over 50%. Prompt identification of the underlying cause of DAH and initiation of appropriate treatment is required in order to prevent acute respiratory failure. When DAH is a manifestation of systemic illness, early targeted treatment can also prevent the development of acute renal failure and the potential subsequent renal death. The standard regimen for remission induction of immune causes is based mainly on high-dose steroids. However, such treatment will be ineffective and potentially deleterious if the DAH is due to nonimmune causes, such as congestive heart failure or infection. Consequently, identification of the cause is crucial for adequate management of a patient with DAH. Over 100 causes of DAH have been reported in immunocompetent patients (Table 1 of the online supplement). Most of the published series focus primarily on immune causes, but numerous nonimmune causes of DAH have been reported as case reports. We recently showed that the global picture of DAH has changed over the last decades; nonimmune causes being largely underestimated. We also reported similar outcome for immune and non-immune causes. This finding challenged the belief that immune DAH exhibits a worse prognosis than non-immune DAH. Based on a retrospective cohort of 112 consecutive immunocompetent patients,

文档评论(0)

daixuefei + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档